November 2, 2024 Tech Titans’ Mixed Results Stall Wall Street Bull Run
October 28, 2024 Recent Oil Slides In Global Markets, Japan In Flux
Amazon: How Andy Jassy’s Merits As CEO Outweigh A Lagging Stock
Apple: Time To Exit As Buffett Sells (Again) Amid China Woes
Amazon: Road To $1 Trillion In Annualized Revenue Is Getting Closer
Amazon: Runway For The Breakout Move Looks Clear
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Hoth Therapeutics (HOTH) stock forecast for 2025
Updated: November 6, 2024 (06:06)
Sector: HealthcareThe share price of Hoth Therapeutics, Inc. (HOTH) now
50/200 Day Moving Average: $0.888 / $1.062
This figure corresponds to the Average Price over the previous 50/200 days. For Hoth Therapeutics stocks, the 50-day moving average is the resistance level today.
For Hoth Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Hoth Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Hoth Therapeutics stock price in 2025. How much will one Hoth Therapeutics share be worth in 2025? Is it worth taking profit / loss on HOTH stock now or waiting? What are analysts' forecasts for Hoth Therapeutics stock?
We forecast Hoth Therapeutics stock performance using neural networks based on historical data on HOTH stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Hoth Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Hoth Therapeutics analysts is $4. Today 200 Day Moving Average is the resistance level (1.062 $). 50 Day Moving Average is the resistance level (0.888 $).
Historical and forecast chart of Hoth Therapeutics, Inc. stock
The chart below shows the historical price of Hoth Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the HOTH stock price can be found in the table below.
Hot Therapeutics, Inc. Is a biopharmaceutical company specializing in targeted therapy for patients with conditions such as atopic dermatitis, also known as eczema. The company develops and commercializes the BioLexa platform. The BioLexa platform is a patented antimicrobial therapy. BioLexa platform captures all zinc ions by adding a chelator called DTPA, which prevents staphylococcal biofilm formation. He intends to explore the possibility of using the BioLexa platform for the treatment of atopic dermatitis or eczema. IT also focuses on exploring the use of the BioLexa platform in aesthetic dermatology to treat and reduce post-operative infections, accelerate healing and improve clinical outcomes for patients undergoing procedures.
Hoth Therapeutics (HOTH) Forecast for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 1.09 | 1.01 | 1.30 | 22.34 % |
Feb | 1.11 | 0.93 | 1.16 | 19.76 % |
Mar | 1.00 | 0.90 | 1.07 | 15.73 % |
Apr | 0.80 | 0.69 | 0.89 | 22.87 % |
May | 0.83 | 0.71 | 0.97 | 27.19 % |
Jun | 0.96 | 0.83 | 1.03 | 19.16 % |
Jul | 0.97 | 0.80 | 1.07 | 24.55 % |
Aug | 1.07 | 0.94 | 1.20 | 21.48 % |
Sep | 1.31 | 1.09 | 1.49 | 26.49 % |
Oct | 1.12 | 1.02 | 1.30 | 21.26 % |
Nov | 1.13 | 1.05 | 1.30 | 18.87 % |
Dec | 1.18 | 0.96 | 1.25 | 23.40 % |
Hoth Therapeutics information and performance
1 ROCKEFELLER PLAZA, SUITE 1039, NEW YORK, NY, US
Market capitalization of the Hoth Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of HOTH shares in the company outstanding by the market price of one share.
EBITDA of Hoth Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Hoth Therapeutics price target for 2025 by month
Target values for the price of one Hoth Therapeutics share for Jan 2025.
In Jan, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.338% volatility is expected.
Pessimistic target level: 1.01
Optimistic target level: 1.30
Target values for the price of one Hoth Therapeutics share for Feb 2025.
In Feb, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 19.762% volatility is expected.
Pessimistic target level: 0.93
Optimistic target level: 1.16
Target values for the price of one Hoth Therapeutics share for Mar 2025.
In Mar, the Negative dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.728% volatility is expected.
Pessimistic target level: 0.90
Optimistic target level: 1.07
Target values for the price of one Hoth Therapeutics share for Apr 2025.
In Apr, the Negative dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 22.870% volatility is expected.
Pessimistic target level: 0.69
Optimistic target level: 0.89
Target values for the price of one Hoth Therapeutics share for May 2025.
In May, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 27.195% volatility is expected.
Pessimistic target level: 0.71
Optimistic target level: 0.97
Target values for the price of one Hoth Therapeutics share for Jun 2025.
In Jun, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 19.159% volatility is expected.
Pessimistic target level: 0.83
Optimistic target level: 1.03
Target values for the price of one Hoth Therapeutics share for Jul 2025.
In Jul, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.545% volatility is expected.
Pessimistic target level: 0.80
Optimistic target level: 1.07
Target values for the price of one Hoth Therapeutics share for Aug 2025.
In Aug, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.476% volatility is expected.
Pessimistic target level: 0.94
Optimistic target level: 1.20
Target values for the price of one Hoth Therapeutics share for Sep 2025.
In Sep, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 26.490% volatility is expected.
Pessimistic target level: 1.09
Optimistic target level: 1.49
Target values for the price of one Hoth Therapeutics share for Oct 2025.
In Oct, the Negative dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.258% volatility is expected.
Pessimistic target level: 1.02
Optimistic target level: 1.30
Target values for the price of one Hoth Therapeutics share for Nov 2025.
In Nov, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.872% volatility is expected.
Pessimistic target level: 1.05
Optimistic target level: 1.30
Target values for the price of one Hoth Therapeutics share for Dec 2025.
In Dec, the Positive dynamics for Hoth Therapeutics, Inc. shares will prevail with possible monthly volatility of 23.404% volatility is expected.
Pessimistic target level: 0.96
Optimistic target level: 1.25
Related stocks from Healthcare sector